CLINICAL_TRIALS
trial_result
· 2025-04-29
Clinical Trial Update: A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005) [Phase 3]
Summary
Phase 3 trial comparing belzutifan to everolimus in advanced renal cell carcinoma; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Carcinoma, Renal Cell | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-04-29